If you have ever purchased or paid for some or all of the purchase price for Prograf or its generic equivalent in capsule form, for consumption by yourself or a member of your family, then you are eligible for a potential award from the Prograf Indirect Purchaser Class Action Lawsuit! Several class action lawsuits against the drug maker were consolidated into a multidistrict litigation claiming Astellas violated various state antitrust, unfair competition, consumer protection, and unjust enrichment laws by filing a bogus citizen petition in September 2007 with the FDA, which delayed the FDA’s approval of generic versions of Prograf. Astellas denies that the petitions delayed the market entry of generic versions of Prograf, however, they have agreed to settle the class-action lawsuit in order to avoid the further risk and cost of ongoing litigation. So if you are eligible, file a claim by 12/06/16 to receive your potential award!
Prograf Class Action Lawsuit:
- Prograf Indirect Purchaser Claim Form
- Claim Form Deadline: 12/06/16
- Who’s Eligible: As a Consumer, you are eligible if between Apr. 15, 2008 and Dec. 31, 2010, you purchased or paid for some or all of the purchase price for Prograf and/or its generic equivalent in capsule form, for consumption by yourself or a member of your family
- Estimated Amount: Varies.
- Proof of Purchase: N/A
- Case Name & Number: In re Prograf Antitrust Litigation, Civil Action No. 1:11-cv-02242-RWZ, in the U.S. District Court for the District of Massachusetts
How to File a Claim:
- Head on over to the Prograf Indirect Purchaser Claim Form.
- Read over the claim form to see if you qualify.
- Fill out the claim form with your information.
- Submit your claim by 12/06/16 to receive your potential award!
Bottom Line:
If you have ever purchased Prograf or its generic equivalent in capsule form, for consumption by yourself or a member of your family, then you are eligible for a potential award from the Prograf Indirect Purchaser Class Action Lawsuit. According to the lawsuit, the drug company wanted to thwart entry of a less expensive generic version of Prograf, an immunosuppressant prescription which is used to prevent organ rejection by kidney, liver, heart and lung transplant patients into the U.S. market. So if you are eligible, file a claim by 12/06/16 to receive your potential award! Don’t forget to take a look at our full list of Class Action Lawsuit Settlements!